(AXTA) Axalta Coating Systems - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: BMG0750C1082

Car Paint, Powder Coating, Industrial Paint, Electrocoat, Clearcoat

AXTA EPS (Earnings per Share)

EPS (Earnings per Share) of AXTA over the last years for every Quarter: "2020-03": 0.22128020347605, "2020-06": -0.35204081632653, "2020-09": 0.34957627118644, "2020-12": 0.29508890770533, "2021-03": 0.064763527907968, "2021-06": 0.54132762312634, "2021-09": 0.29952319029042, "2021-12": 0.23241590214067, "2022-03": 0.18428063943162, "2022-06": 0.19918699186992, "2022-09": 0.28209764918626, "2022-12": 0.19683972911964, "2023-03": 0.27465105808195, "2023-06": 0.27370786516854, "2023-09": 0.32852636322668, "2023-12": 0.33091896785876, "2024-03": 0.18526886579304, "2024-06": 0.50701674966048, "2024-09": 0.4572204617474, "2024-12": 0.62471500227998, "2025-03": 0.45123062898815, "2025-06": 0.49794426678849,

AXTA Revenue

Revenue of AXTA over the last years for every Quarter: 2020-03: 983.5, 2020-06: 652.7, 2020-09: 1026.9, 2020-12: 1074.5, 2021-03: 1063.6, 2021-06: 1126.8, 2021-09: 1088.6, 2021-12: 1137.2, 2022-03: 1174.1, 2022-06: 1234.9, 2022-09: 1238.7, 2022-12: 1236.7, 2023-03: 1284, 2023-06: 1293.9, 2023-09: 1309, 2023-12: 1297.3, 2024-03: 1294, 2024-06: 1351, 2024-09: 1320, 2024-12: 1311, 2025-03: 1262, 2025-06: 1305,

Description: AXTA Axalta Coating Systems

Axalta Coating Systems Ltd. is a global leader in the manufacture and distribution of high-performance coatings systems, operating across multiple regions and segments, including Performance Coatings and Mobility Coatings. The companys diverse product portfolio caters to various industries, such as automotive, industrial, and construction, under numerous brand names.

To further analyze Axaltas performance, we can examine key performance indicators (KPIs) such as revenue growth, EBITDA margin, and debt-to-equity ratio. Axaltas revenue growth has been driven by its global presence and diversification across various end-markets. The companys EBITDA margin is a key indicator of its operational efficiency, and its ability to maintain a stable margin amidst fluctuations in raw material prices is crucial. Additionally, Axaltas debt-to-equity ratio is an important metric to assess its capital structure and leverage.

From a financial perspective, Axaltas market capitalization stands at approximately $6.76 billion, with a price-to-earnings (P/E) ratio of 15.09 and a forward P/E ratio of 12.09. The companys return on equity (RoE) is 23.43%, indicating a relatively strong return for shareholders. To gain a deeper understanding of Axaltas valuation, we can compare its P/E ratio to that of its peers in the Specialty Chemicals industry.

To identify potential trading opportunities, we can analyze Axaltas stock price movements and trends. By examining the companys historical price data, we can observe its volatility and identify potential support and resistance levels. Furthermore, we can use technical indicators such as moving averages and relative strength index (RSI) to gauge the stocks momentum and sentiment.

AXTA Stock Overview

Market Cap in USD 6,811m
Sub-Industry Specialty Chemicals
IPO / Inception 2014-11-12

AXTA Stock Ratings

Growth Rating -8.42%
Fundamental 70.0%
Dividend Rating -
Return 12m vs S&P 500 -25.6%
Analyst Rating 4.10 of 5

AXTA Dividends

Currently no dividends paid

AXTA Growth Ratios

Growth Correlation 3m 8.7%
Growth Correlation 12m -81.3%
Growth Correlation 5y 54.2%
CAGR 5y 5.58%
CAGR/Max DD 5y 0.15
Sharpe Ratio 12m -0.03
Alpha -27.41
Beta 0.876
Volatility 25.58%
Current Volume 1300.1k
Average Volume 20d 2627.6k
Stop Loss 30.3 (-3.1%)
Signal 0.39

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (446.0m TTM) > 0 and > 6% of Revenue (6% = 311.9m TTM)
FCFTA 0.05 (>2.0%) and ΔFCFTA -1.96pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 30.42% (prev 31.97%; Δ -1.56pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.08 (>3.0%) and CFO 598.0m > Net Income 446.0m (YES >=105%, WARN >=100%)
Net Debt (-605.0m) to EBITDA (1.10b) ratio: -0.55 <= 3.0 (WARN <= 3.5)
Current Ratio 2.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (218.9m) change vs 12m ago -0.91% (target <= -2.0% for YES)
Gross Margin 33.69% (prev 32.64%; Δ 1.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 68.91% (prev 71.88%; Δ -2.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 4.16 (EBITDA TTM 1.10b / Interest Expense TTM 194.0m) >= 6 (WARN >= 3)

Altman Z'' 3.18

(A) 0.20 = (Total Current Assets 2.99b - Total Current Liabilities 1.41b) / Total Assets 7.78b
(B) 0.24 = Retained Earnings (Balance) 1.89b / Total Assets 7.78b
(C) 0.11 = EBIT TTM 808.0m / Avg Total Assets 7.54b
(D) 0.32 = Book Value of Equity 1.76b / Total Liabilities 5.47b
Total Rating: 3.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 69.95

1. Piotroski 6.0pt = 1.0
2. FCF Yield 4.32% = 2.16
3. FCF Margin 7.98% = 2.00
4. Debt/Equity 1.51 = 1.46
5. Debt/Ebitda 3.12 = -1.92
6. ROIC - WACC 5.08% = 6.35
7. RoE 21.87% = 1.82
8. Rev. Trend 53.75% = 2.69
9. Rev. CAGR 1.91% = 0.24
10. EPS Trend 74.34% = 1.86
11. EPS CAGR 22.95% = 2.30

What is the price of AXTA shares?

As of August 31, 2025, the stock is trading at USD 31.26 with a total of 1,300,096 shares traded.
Over the past week, the price has changed by -1.76%, over one month by +8.92%, over three months by +0.16% and over the past year by -12.97%.

Is Axalta Coating Systems a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Axalta Coating Systems (NYSE:AXTA) is currently (August 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 69.95 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AXTA is around 28.63 USD . This means that AXTA is currently overvalued and has a potential downside of -8.41%.

Is AXTA a buy, sell or hold?

Axalta Coating Systems has received a consensus analysts rating of 4.10. Therefore, it is recommended to buy AXTA.
  • Strong Buy: 9
  • Buy: 4
  • Hold: 7
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the AXTA price?

Issuer Target Up/Down from current
Wallstreet Target Price 37.4 19.8%
Analysts Target Price 37.4 19.8%
ValueRay Target Price 31.4 0.3%

Last update: 2025-08-28 04:32

AXTA Fundamental Data Overview

Market Cap USD = 6.81b (6.81b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 625.0m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 15.4167
P/E Forward = 12.4844
P/S = 1.3104
P/B = 3.0072
P/EG = 2.02
Beta = 1.272
Revenue TTM = 5.20b USD
EBIT TTM = 808.0m USD
EBITDA TTM = 1.10b USD
Long Term Debt = 3.40b USD (from longTermDebt, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 3.42b USD (Calculated: Short Term 20.0m + Long Term 3.40b)
Net Debt = -605.0m USD (from netDebt column, last quarter)
Enterprise Value = 9.60b USD (6.81b + Debt 3.42b - CCE 625.0m)
Interest Coverage Ratio = 4.16 (Ebit TTM 808.0m / Interest Expense TTM 194.0m)
FCF Yield = 4.32% (FCF TTM 415.0m / Enterprise Value 9.60b)
FCF Margin = 7.98% (FCF TTM 415.0m / Revenue TTM 5.20b)
Net Margin = 8.58% (Net Income TTM 446.0m / Revenue TTM 5.20b)
Gross Margin = 33.69% ((Revenue TTM 5.20b - Cost of Revenue TTM 3.45b) / Revenue TTM)
Tobins Q-Ratio = 5.46 (Enterprise Value 9.60b / Book Value Of Equity 1.76b)
Interest Expense / Debt = 1.43% (Interest Expense 49.0m / Debt 3.42b)
Taxrate = 21.17% (from yearly Income Tax Expense: 105.0m / 496.0m)
NOPAT = 637.0m (EBIT 808.0m * (1 - 21.17%))
Current Ratio = 2.12 (Total Current Assets 2.99b / Total Current Liabilities 1.41b)
Debt / Equity = 1.51 (Debt 3.42b / last Quarter total Stockholder Equity 2.27b)
Debt / EBITDA = 3.12 (Net Debt -605.0m / EBITDA 1.10b)
Debt / FCF = 8.23 (Debt 3.42b / FCF TTM 415.0m)
Total Stockholder Equity = 2.04b (last 4 quarters mean)
RoA = 5.73% (Net Income 446.0m, Total Assets 7.78b )
RoE = 21.87% (Net Income TTM 446.0m / Total Stockholder Equity 2.04b)
RoCE = 14.87% (Ebit 808.0m / (Equity 2.04b + L.T.Debt 3.40b))
RoIC = 11.61% (NOPAT 637.0m / Invested Capital 5.48b)
WACC = 6.53% (E(6.81b)/V(10.23b) * Re(9.24%)) + (D(3.42b)/V(10.23b) * Rd(1.43%) * (1-Tc(0.21)))
Shares Correlation 5-Years: -100.0 | Cagr: -1.11%
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 74.23% ; FCFE base≈462.2m ; Y1≈467.9m ; Y5≈508.5m
Fair Price DCF = 33.56 (DCF Value 7.27b / Shares Outstanding 216.6m; 5y FCF grow 0.86% → 3.0% )
Revenue Correlation: 53.75 | Revenue CAGR: 1.91%
Rev Growth-of-Growth: -4.86
EPS Correlation: 74.34 | EPS CAGR: 22.95%
EPS Growth-of-Growth: 15.18

Additional Sources for AXTA Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle